Literature DB >> 16717251

Proteasomal dysfunction in sporadic Parkinson's disease.

Kevin St P McNaught1, Tehone Jackson, Ruth JnoBaptiste, Alexander Kapustin, C Warren Olanow.   

Abstract

The cause and mechanism of neuronal death in sporadic Parkinson's disease (PD) continue to elude investigators. Recently, alterations in proteasomal function have been detected in the brain of patients with the illness. The biochemical basis of the defect and its relevance to the disease process are now being studied. The available results suggest that proteasomal dysfunction could underlie protein accumulation, Lewy body formation, and neuron death in PD. The cause of proteasomal dysfunction is unknown at present, but this could relate to gene mutations, oxidative damage, ATP depletion, or the actions of environmental toxins. It remains to be established if proteasomal dysfunction plays a primary or a secondary role in the initiation or progression of the neurodegenerative process in PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16717251     DOI: 10.1212/wnl.66.10_suppl_4.s37

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

Review 1.  A possible pathophysiological role of tyrosine hydroxylase in Parkinson's disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer.

Authors:  Akira Nakashima; Akira Ota; Yoko S Kaneko; Keiji Mori; Hiroshi Nagasaki; Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2012-05-27       Impact factor: 3.575

2.  PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.

Authors:  Xuefei Zhang; Xiaoqing Ren; Qi Zhang; Zheyi Li; Shuaipeng Ma; Jintao Bao; Zeyang Li; Xue Bai; Liangjun Zheng; Zhong Zhang; Shujiang Shang; Chen Zhang; Chuangui Wang; Liu Cao; Qingsong Wang; Jianguo Ji
Journal:  Antioxid Redox Signal       Date:  2015-11-19       Impact factor: 8.401

3.  gp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 and 2.

Authors:  Xiao Shi; Beth A Habecker
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

4.  Proteomics analysis of human brain tissue infected by street rabies virus.

Authors:  Firouzeh Farahtaj; Fatemeh Zandi; Vahid Khalaj; Peyvand Biglari; Ahmad Fayaz; Behrouz Vaziri
Journal:  Mol Biol Rep       Date:  2013-09-24       Impact factor: 2.316

Review 5.  Neuroprotection in Parkinson's disease: myth or reality?

Authors:  Tiffini Voss; Bernard Ravina
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

6.  Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.

Authors:  Giulia Ambrosi; Natasa Kustrimovic; Francesca Siani; Emanuela Rasini; Silvia Cerri; Cristina Ghezzi; Giuseppe Dicorato; Sofia Caputo; Franca Marino; Marco Cosentino; Fabio Blandini
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

7.  Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease.

Authors:  W Michael Caudle; Sheng Pan; Min Shi; Thomas Quinn; Jake Hoekstra; Richard P Beyer; Thomas J Montine; Jing Zhang
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

8.  Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS.

Authors:  N D Schmitt; J N Agar
Journal:  J Mass Spectrom       Date:  2017-07       Impact factor: 1.982

9.  Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

10.  N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.

Authors:  Mary J Holmay; Melissa Terpstra; Lisa D Coles; Usha Mishra; Matthew Ahlskog; Gülin Öz; James C Cloyd; Paul J Tuite
Journal:  Clin Neuropharmacol       Date:  2013 Jul-Aug       Impact factor: 1.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.